Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension study of pregabalin (Lyrica) monotherapy in partial seizures
2009-016850-42Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pregabalin in Focal onset seizure, sponsored by Pfizer. Primary endpoints: Long-term safety of pregabalin monotherapy and Long-term efficacy of pregabalin monotherapy. Started Mar 2010; status: completed.
02
Drugs
pregabalin
03
Conditions
Focal onset seizure
Beyond the preview
Go deeper on 2009-016850-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016850-42.